8 unchanged sentences
Holders of Record
−Removed: At March 4, 2022, we had 48,146,865 shares of common stock outstanding held by approximately 140 stockholders of record of our common stock.
+Added: At February 22, 2023, we had 47,896,820 shares of common stock outstanding held by approximately 135 stockholders of record of our common stock.
We believe the actual number of stockholders is greater than this number of record holders, including stockholders who are beneficial owners but whose shares are held in “street” name by brokers and other nominees.
4 unchanged sentences
The following graph illustrates a comparison of the total cumulative stockholder return on our common stock since December 31, 2017, with the cumulative stockholder return since December 31, 2017, on two indices:
−Removed: the Nasdaq Composite Index and the Nasdaq Pharmaceutical Index.
+Added: the Nasdaq Composite Index and the Nasdaq Biotechnology Index.
The graph assumes an initial investment of $100 on December 31, 2017, both in our common stock and each index.
14 unchanged sentences
December 1 – December 31, 2022
−Removed: (1) On August 6, 2020, we announced that our Board of Directors authorized an increase of $20 million to our share buyback program.
−Removed: On August 9, 2021, we announced that our Board of Directors authorized an increase of $20 million to our share buyback program.
+Added: (1) On November 7, 2022, we announced that our Board of Directors authorized an increase of $50.0 million to our share buyback program.
+Added: As of December 31, 2022, $43.6 million remained available for repurchase under such program.
The share buyback program does not have an expiration date.
−Removed: As of December 31, 2021, $8.5 million remained available for repurchase under the program.
Recent Sales of Unregistered Securities
−Removed: There were no sales of unregistered securities during fiscal 2021 other than transactions previously reported in a Quarterly Report on Form 10-Q or a Current Report on Form 8-K.
−Removed: Securities Authorized for Issuance Under Equity Compensation Plans
−Removed: See Item 12, “Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters” for information regarding securities authorized for issuance.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.